{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:04:14Z","timestamp":1787868254539,"version":"build-2784847793"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Egyptian Atomic Energy Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dual-tail strategy has been successfully utilized in the development of novel carbonic anhydrase IX (CA IX) inhibitors. Herein we adopted this approach in the design and synthesis of a series of novel pyridine sulfonamide-pyrazole hybrid scaffold mimicking dual-tail inhibitors of CA IX. A library of 15 compounds was synthesized and assessed for their potential cytotoxic effects against colorectal cancer cells. Compounds\n                    <jats:bold>3<\/jats:bold>\n                    , and\n                    <jats:bold>11<\/jats:bold>\n                    induced potential cytotoxic effects against the three cancer cell lines (HCT-116, HT-29, and SW-620) with IC\n                    <jats:sub>50<\/jats:sub>\n                    s\u2019 of 45.88, 28.27, and 16.57 uM, 25.01, 8.99, and 3.27\u00a0\u00b5M, respectively. Both compounds induced cellular apoptosis on HCT-116 and SW-620 cells, while compound\n                    <jats:bold>3<\/jats:bold>\n                    induced necrosis as well. In addition, both compounds induced cell cycle arrest on G0\/G1, and S phases. Also, compound\n                    <jats:bold>11<\/jats:bold>\n                    showed potential autophagy induction on both colon cancer cell lines (HCT-116, and HT-29), and a little bit on metastatic type. Both compounds were less cytotoxic than the reference drug on normal epithelial cell. The migration rates of HCT-116 and the metastatic one SW-620 were reduced by both compounds. Finally, molecular docking of compounds\n                    <jats:bold>3<\/jats:bold>\n                    and\n                    <jats:bold>11<\/jats:bold>\n                    into the active site of CA IX confirmed in vitro inhibitory activity for both compounds.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-32820-0","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T11:02:34Z","timestamp":1680951754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pyrazole-sulfonamide scaffold featuring dual-tail strategy as apoptosis inducers in colon cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"Reham M. M.","family":"El-Hazek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashwa H.","family":"Zaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagar E. S.","family":"Emam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa G.","family":"El-Gazzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,8]]},"reference":[{"key":"32820_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold, M. et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 66, 683\u2013691. https:\/\/doi.org\/10.1136\/gutjnl-2015-310912 (2017).","journal-title":"Gut"},{"key":"32820_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.12865\/chsj.45.02.02","volume":"45","author":"RM Florescu-\u0162enea","year":"2019","unstructured":"Florescu-\u0162enea, R. M. et al. Colorectal cancer: An update on treatment options and future perspectives. Curr. Health Sci. J. 45, 134\u2013141. https:\/\/doi.org\/10.12865\/chsj.45.02.02 (2019).","journal-title":"Curr. Health Sci. J."},{"key":"32820_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.4251\/wjgo.v12.i8.808","volume":"12","author":"S Chakrabarti","year":"2020","unstructured":"Chakrabarti, S., Peterson, C. Y., Sriram, D. & Mahipal, A. Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions. World J. Gastrointest. Oncol. 12, 808\u2013832. https:\/\/doi.org\/10.4251\/wjgo.v12.i8.808 (2020).","journal-title":"World J. Gastrointest. Oncol."},{"key":"32820_CR4","doi-asserted-by":"publisher","first-page":"11559","DOI":"10.18632\/oncotarget.24338","volume":"9","author":"K Morawska","year":"2018","unstructured":"Morawska, K. et al. 5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer. Oncotarget 9, 11559\u201311571. https:\/\/doi.org\/10.18632\/oncotarget.24338 (2018).","journal-title":"Oncotarget"},{"key":"32820_CR5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3390\/molecules13081551","volume":"13","author":"N Zhang","year":"2008","unstructured":"Zhang, N., Yin, Y., Xu, S. J. & Chen, W. S. 5-Fluorouracil: Mechanisms of resistance and reversal strategies. Molecules 13, 1551\u20131569. https:\/\/doi.org\/10.3390\/molecules13081551 (2008).","journal-title":"Molecules"},{"key":"32820_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1200\/jco.2000.18.1.136","volume":"18","author":"S Giacchetti","year":"2000","unstructured":"Giacchetti, S. et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J. Clin. Oncol. 18, 136\u2013147. https:\/\/doi.org\/10.1200\/jco.2000.18.1.136 (2000).","journal-title":"J. Clin. Oncol."},{"key":"32820_CR7","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/s0140-6736(00)02034-1","volume":"355","author":"JY Douillard","year":"2000","unstructured":"Douillard, J. Y. et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial. Lancet 355, 1041\u20131047. https:\/\/doi.org\/10.1016\/s0140-6736(00)02034-1 (2000).","journal-title":"Lancet"},{"key":"32820_CR8","first-page":"1799","volume":"9","author":"T Miyashita","year":"1994","unstructured":"Miyashita, T. et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799\u20131805 (1994).","journal-title":"Oncogene"},{"key":"32820_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ijc.11176","volume":"106","author":"CN Arnold","year":"2003","unstructured":"Arnold, C. N., Goel, A. & Boland, C. R. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Int. J. Cancer 106, 66\u201373. https:\/\/doi.org\/10.1002\/ijc.11176 (2003).","journal-title":"Int. J. Cancer"},{"key":"32820_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40959-019-0048-3","volume":"5","author":"C Yuan","year":"2019","unstructured":"Yuan, C., Parekh, H., Allegra, C., George, T. J. & Starr, J. S. 5-FU induced cardiotoxicity: Case series and review of the literature. Cardio-Oncology 5, 13. https:\/\/doi.org\/10.1186\/s40959-019-0048-3 (2019).","journal-title":"Cardio-Oncology"},{"key":"32820_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00213-011-2466-2","volume":"220","author":"JE Fardell","year":"2012","unstructured":"Fardell, J. E., Vardy, J., Shah, J. D. & Johnston, I. N. Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology 220, 183\u2013193. https:\/\/doi.org\/10.1007\/s00213-011-2466-2 (2012).","journal-title":"Psychopharmacology"},{"key":"32820_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"JF Kerr","year":"1972","unstructured":"Kerr, J. F., Wyllie, A. H. & Currie, A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239\u2013257. https:\/\/doi.org\/10.1038\/bjc.1972.33 (1972).","journal-title":"Br. J. Cancer"},{"key":"32820_CR13","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1136\/gut.2004.052704","volume":"53","author":"AJ Watson","year":"2004","unstructured":"Watson, A. J. Apoptosis and colorectal cancer. Gut 53, 1701\u20131709. https:\/\/doi.org\/10.1136\/gut.2004.052704 (2004).","journal-title":"Gut"},{"key":"32820_CR14","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1128\/mcb.25.21.9369-9382.2005","volume":"25","author":"Y Takahashi","year":"2005","unstructured":"Takahashi, Y. et al. Loss of Bif-1 suppresses Bax\/Bak conformational change and mitochondrial apoptosis. Mol. Cell. Biol. 25, 9369\u20139382. https:\/\/doi.org\/10.1128\/mcb.25.21.9369-9382.2005 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"32820_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1615\/CritRevOncog.2016016987","volume":"21","author":"L Nonnenmacher","year":"2016","unstructured":"Nonnenmacher, L. et al. Cell death induction in cancer therapy\u2014Past, present, and future. Crit. Rev. Oncog. 21, 253\u2013267. https:\/\/doi.org\/10.1615\/CritRevOncog.2016016987 (2016).","journal-title":"Crit. Rev. Oncog."},{"key":"32820_CR16","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3390\/ijms19113466","volume":"19","author":"CW Yun","year":"2018","unstructured":"Yun, C. W. & Lee, S. H. The roles of autophagy in cancer. Int. J. Mol. Sci. 19, 3466. https:\/\/doi.org\/10.3390\/ijms19113466 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"32820_CR17","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1101\/gad.1599207","volume":"21","author":"N Mizushima","year":"2007","unstructured":"Mizushima, N. Autophagy: Process and function. Genes Dev. 21, 2861\u20132873. https:\/\/doi.org\/10.1101\/gad.1599207 (2007).","journal-title":"Genes Dev."},{"issue":"Suppl 2","key":"32820_CR18","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/sj.cdd.4401728","volume":"12","author":"N Mizushima","year":"2005","unstructured":"Mizushima, N. The pleiotropic role of autophagy: From protein metabolism to bactericide. Cell Death Differ. 12(Suppl 2), 1535\u20131541. https:\/\/doi.org\/10.1038\/sj.cdd.4401728 (2005).","journal-title":"Cell Death Differ."},{"key":"32820_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.cdd.4400950","volume":"9","author":"JC Ameisen","year":"2002","unstructured":"Ameisen, J. C. On the origin, evolution, and nature of programmed cell death: A timeline of four billion years. Cell Death Differ. 9, 367\u2013393. https:\/\/doi.org\/10.1038\/sj.cdd.4400950 (2002).","journal-title":"Cell Death Differ."},{"key":"32820_CR20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/carcin\/bgr031","volume":"32","author":"MT Rosenfeldt","year":"2011","unstructured":"Rosenfeldt, M. T. & Ryan, K. M. The multiple roles of autophagy in cancer. Carcinogenesis 32, 955\u2013963. https:\/\/doi.org\/10.1093\/carcin\/bgr031 (2011).","journal-title":"Carcinogenesis"},{"key":"32820_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/2789_2008_087","volume-title":"Ernst Schering Foundation Symposium Proceedings","author":"E White","year":"2008","unstructured":"White, E. Role of the metabolic stress responses of apoptosis and autophagy in tumor suppression. In Ernst Schering Foundation Symposium Proceedings (eds Kroemer, G. et al.) 23\u201334 (Springer, 2008). https:\/\/doi.org\/10.1007\/2789_2008_087."},{"key":"32820_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10555-019-09787-4","volume":"38","author":"A Ibrahim-Hashim","year":"2019","unstructured":"Ibrahim-Hashim, A. & Estrella, V. Acidosis and cancer: From mechanism to neutralization. Cancer Metastasis Rev. 38, 149\u2013155. https:\/\/doi.org\/10.1007\/s10555-019-09787-4 (2019).","journal-title":"Cancer Metastasis Rev."},{"key":"32820_CR23","doi-asserted-by":"publisher","first-page":"13405","DOI":"10.3390\/ijms222413405","volume":"22","author":"S Kalinin","year":"2021","unstructured":"Kalinin, S. et al. Carbonic anhydrase IX inhibitors as candidates for combination therapy of solid tumors. Int. J. Mol. Sci. 22, 13405. https:\/\/doi.org\/10.3390\/ijms222413405 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"32820_CR24","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.3390\/ijms22116098","volume":"22","author":"E Temiz","year":"2021","unstructured":"Temiz, E. et al. Inhibition of carbonic anhydrase IX promotes apoptosis through intracellular pH level alterations in cervical cancer cells. Int. J. Mol. Sci. 22, 6098. https:\/\/doi.org\/10.3390\/ijms22116098 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"32820_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/14756366.2018.1524380","volume":"34","author":"I Koyuncu","year":"2019","unstructured":"Koyuncu, I. et al. Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line. J. Enzym. Inhib. Med. Chem. 34, 75\u201386. https:\/\/doi.org\/10.1080\/14756366.2018.1524380 (2019).","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"32820_CR26","doi-asserted-by":"publisher","first-page":"7608","DOI":"10.1073\/pnas.95.13.7608","volume":"95","author":"O T\u00fcreci","year":"1998","unstructured":"T\u00fcreci, O. et al. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc. Natl. Acad. Sci. U.S.A. 95, 7608\u20137613. https:\/\/doi.org\/10.1073\/pnas.95.13.7608 (1998).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"32820_CR27","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/ijc.25491","volume":"128","author":"MI Ilie","year":"2011","unstructured":"Ilie, M. I. et al. Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis. Int. J. Cancer 128, 1614\u20131623. https:\/\/doi.org\/10.1002\/ijc.25491 (2011).","journal-title":"Int. J. Cancer"},{"key":"32820_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/14756366.2016.1177525","volume":"31","author":"C Federici","year":"2016","unstructured":"Federici, C. et al. Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells. J. Enzym. Inhib. Med. Chem. 31, 119\u2013125. https:\/\/doi.org\/10.1080\/14756366.2016.1177525 (2016).","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"32820_CR29","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","volume":"25","author":"F Carta","year":"2017","unstructured":"Carta, F., Vullo, D., Osman, S. M., AlOthman, Z. & Supuran, C. T. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs. Bioorg. Med. Chem. 25, 2569\u20132576. https:\/\/doi.org\/10.1016\/j.bmc.2017.03.027 (2017).","journal-title":"Bioorg. Med. Chem."},{"key":"32820_CR30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/coc.0000000000000691","volume":"43","author":"PC McDonald","year":"2020","unstructured":"McDonald, P. C. et al. A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors. Am. J. Clin. Oncol. 43, 484\u2013490. https:\/\/doi.org\/10.1097\/coc.0000000000000691 (2020).","journal-title":"Am. J. Clin. Oncol."},{"key":"32820_CR31","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2022-0197","author":"NH Zaher","year":"2023","unstructured":"Zaher, N. H., Elhazek, R. M., Gouda, A. E., Khalil, A. & El-Gazzar, M. G. Challenging breast cancer through novel sulfonamide-pyridine hybrids: Design, synthesis, carbonic anhydrase IX inhibition and induction of apoptosis. Future Med. Chem. https:\/\/doi.org\/10.4155\/fmc-2022-0197 (2023).","journal-title":"Future Med. Chem."},{"key":"32820_CR32","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1021\/jm101541x","volume":"54","author":"F Pacchiano","year":"2011","unstructured":"Pacchiano, F. et al. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J. Med. Chem. 54, 1896\u20131902. https:\/\/doi.org\/10.1021\/jm101541x (2011).","journal-title":"J. Med. Chem."},{"key":"32820_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","volume":"22","author":"M Bozdag","year":"2014","unstructured":"Bozdag, M. et al. Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: Solution and X-ray crystallographic studies. Bioorg. Med. Chem. 22, 334\u2013340. https:\/\/doi.org\/10.1016\/j.bmc.2013.11.016 (2014).","journal-title":"Bioorg. Med. Chem."},{"key":"32820_CR34","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1021\/acsmedchemlett.7b00399","volume":"8","author":"A Nocentini","year":"2017","unstructured":"Nocentini, A. et al. Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases. ACS Med. Chem. Lett. 8, 1314\u20131319. https:\/\/doi.org\/10.1021\/acsmedchemlett.7b00399 (2017).","journal-title":"ACS Med. Chem. Lett."},{"key":"32820_CR35","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1021\/jm501798g","volume":"58","author":"RP Tanpure","year":"2015","unstructured":"Tanpure, R. P. et al. Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site. J. Med. Chem. 58, 1494\u20131501. https:\/\/doi.org\/10.1021\/jm501798g (2015).","journal-title":"J. Med. Chem."},{"key":"32820_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2018.04.016","volume":"152","author":"HS Ibrahim","year":"2018","unstructured":"Ibrahim, H. S. et al. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform. Eur. J. Med. Chem. 152, 1\u20139 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"32820_CR37","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/ijms23010130","volume":"23","author":"A Zak\u0161auskas","year":"2021","unstructured":"Zak\u0161auskas, A. et al. Methyl 2-halo-4-substituted-5-sulfamoyl-benzoates as high affinity and selective inhibitors of carbonic anhydrase IX. Int. J. Mol. Sci. 23, 130. https:\/\/doi.org\/10.3390\/ijms23010130 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"32820_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1573407213666170828165512","volume":"15","author":"P Shukla","year":"2019","unstructured":"Shukla, P., Sharma, A., Fageria, L. & Chowdhury, R. Novel spiro\/non-spiro pyranopyrazoles: Eco-friendly synthesis, in-vitro anticancer activity, DNA binding, and in-silico docking studies. Curr. Bioact. Compd. 15, 257\u2013267 (2019).","journal-title":"Curr. Bioact. Compd."},{"key":"32820_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2019.00917","author":"NM Saleh","year":"2020","unstructured":"Saleh, N. M., El-Gazzar, M. G., Aly, H. M. & Othman, R. A. Novel anticancer fused pyrazole derivatives as EGFR and VEGFR-2 Dual TK inhibitors. Front. Chem. https:\/\/doi.org\/10.3389\/fchem.2019.00917 (2020).","journal-title":"Front. Chem."},{"key":"32820_CR40","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1039\/C6MD00367B","volume":"7","author":"FA Ragab","year":"2016","unstructured":"Ragab, F. A. et al. Synthesis of novel thiadiazole derivatives as selective COX-2 inhibitors. MedChemComm 7, 2309\u20132327. https:\/\/doi.org\/10.1039\/C6MD00367B (2016).","journal-title":"MedChemComm"},{"key":"32820_CR41","doi-asserted-by":"publisher","first-page":"126851","DOI":"10.1016\/j.bmcl.2019.126851","volume":"30","author":"SS Maranh\u00e3o","year":"2020","unstructured":"Maranh\u00e3o, S. S. et al. Synthesis of PJOV56, a new quinoxalinyl-hydrazone derivative able to induce autophagy and apoptosis in colorectal cancer cells, and related compounds. Bioorg. Med. Chem. Lett. 30, 126851. https:\/\/doi.org\/10.1016\/j.bmcl.2019.126851 (2020).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"32820_CR42","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/ijms19020448","volume":"19","author":"CM Pfeffer","year":"2018","unstructured":"Pfeffer, C. M. & Singh, A. T. K. Apoptosis: A target for anticancer therapy. Int. J. Mol. Sci. 19, 448. https:\/\/doi.org\/10.3390\/ijms19020448 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"32820_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RSY Wong","year":"2011","unstructured":"Wong, R. S. Y. Apoptosis in cancer: From pathogenesis to treatment. J. Exp. Clin. Cancer Res. 30, 87. https:\/\/doi.org\/10.1186\/1756-9966-30-87 (2011).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"32820_CR44","doi-asserted-by":"publisher","first-page":"111730","DOI":"10.1016\/j.biopha.2021.111730","volume":"140","author":"RA Algehani","year":"2021","unstructured":"Algehani, R. A. et al. Colossolactone-G synergizes the anticancer properties of 5-fluorouracil and gemcitabine against colorectal cancer cells. Biomed. Pharmacother. 140, 111730. https:\/\/doi.org\/10.1016\/j.biopha.2021.111730 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"32820_CR45","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/nrm1493","volume":"5","author":"J Bartek","year":"2004","unstructured":"Bartek, J., Lukas, C. & Lukas, J. Checking on DNA damage in S phase. Nat. Rev. Mol. Cell Biol. 5, 792\u2013804. https:\/\/doi.org\/10.1038\/nrm1493 (2004).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"32820_CR46","doi-asserted-by":"publisher","first-page":"47619","DOI":"10.18632\/oncotarget.17411","volume":"8","author":"Z Zheng","year":"2017","unstructured":"Zheng, Z. et al. Peiminine inhibits colorectal cancer cell proliferation by inducing apoptosis and autophagy and modulating key metabolic pathways. Oncotarget 8, 47619\u201347631. https:\/\/doi.org\/10.18632\/oncotarget.17411 (2017).","journal-title":"Oncotarget"},{"key":"32820_CR47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10495-014-0967-2","volume":"19","author":"S Mukhopadhyay","year":"2014","unstructured":"Mukhopadhyay, S., Panda, P. K., Sinha, N., Das, D. N. & Bhutia, S. K. Autophagy and apoptosis: Where do they meet?. Apoptosis 19, 555\u2013566. https:\/\/doi.org\/10.1007\/s10495-014-0967-2 (2014).","journal-title":"Apoptosis"},{"key":"32820_CR48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/ijms23010130","volume":"23","author":"A Zak\u0161auskas","year":"2022","unstructured":"Zak\u0161auskas, A. et al. Methyl 2-halo-4-substituted-5-sulfamoyl-benzoates as high affinity and selective inhibitors of carbonic anhydrase IX. Int. J. Mol. Sci. 23, 130 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"32820_CR49","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334 (2010).","journal-title":"J. Comput. Chem."},{"key":"32820_CR50","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1021\/ci500209e","volume":"54","author":"D Santos-Martins","year":"2014","unstructured":"Santos-Martins, D., Forli, S., Ramos, M. J. & Olson, A. J. AutoDock4(Zn): An improved AutoDock force field for small-molecule docking to zinc metalloproteins. J. Chem. Inf. Model. 54, 2371\u20132379. https:\/\/doi.org\/10.1021\/ci500209e (2014).","journal-title":"J. Chem. Inf. Model."},{"key":"32820_CR51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/jcc.20634","volume":"28","author":"R Huey","year":"2007","unstructured":"Huey, R., Morris, G. M., Olson, A. J. & Goodsell, D. S. A semiempirical free energy force field with charge-based desolvation. J. Comput. Chem. 28, 1145\u20131152. https:\/\/doi.org\/10.1002\/jcc.20634 (2007).","journal-title":"J. Comput. Chem."},{"key":"32820_CR52","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13321-019-0362-7","volume":"11","author":"EW Bell","year":"2019","unstructured":"Bell, E. W. & Zhang, Y. DockRMSD: An open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism. J. Cheminform. 11, 40. https:\/\/doi.org\/10.1186\/s13321-019-0362-7 (2019).","journal-title":"J. Cheminform."},{"key":"32820_CR53","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.radphyschem.2010.04.014","volume":"79","author":"BK Singh","year":"2010","unstructured":"Singh, B. K., Parwate, D. V., Das Sarma, I. B. & Shukla, S. K. Study on gamma and electron beam sterilization of third generation cephalosporins cefdinir and cefixime in solid state. Radiat. Phys. Chem. 79, 1079\u20131087. https:\/\/doi.org\/10.1016\/j.radphyschem.2010.04.014 (2010).","journal-title":"Radiat. Phys. Chem."},{"key":"32820_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejbt.2016.11.009","volume":"25","author":"P Zalewski","year":"2017","unstructured":"Zalewski, P. et al. Radiolytic studies of cefozopran hydrochloride in the solid state. Electron. J. Biotechnol. 25, 28\u201332. https:\/\/doi.org\/10.1016\/j.ejbt.2016.11.009 (2017).","journal-title":"Electron. J. Biotechnol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32820-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32820-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32820-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T11:04:42Z","timestamp":1680951882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32820-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,8]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["32820"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-32820-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2394883\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,8]]},"assertion":[{"value":"19 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5782"}}